IN THE NEWS

NEW YORK (Reuters) – Life sciences company Bayer AG said on Friday it would discontinue the sale of its birth control product Essure in the United States, citing a decline in sales of the implantable device that made the business no longer sustainable. The decision followed an announcement by the...

Women banded together to force a pharmaceutical company to reckon with the devastating side effects of its controversial product. Since 2002, Essure has been marketed as a permanent birth control method for women that is convenient and can be performed in their own doctor’s office. The procedure is simple: A...